Literature DB >> 10022750

Lack of association between the dopamine D2 receptor gene allele DRD2*A1 and cigarette smoking in a United Kingdom population.

A B Singleton1, J H Thomson, C M Morris, J A Court, S Lloyd, S Cholerton.   

Abstract

The dopamine D2 receptor gene contains a TaqI repeat fragment length polymorphism creating two alleles DRD2*A1 and DRD2*A2. It has been previously suggested that the lesser allele, DRD2*A1, is more prevalent in individuals who are susceptible to impulsive/addictive/compulsive behaviour, for example, alcoholics, polysubstance abusers and tobacco smokers. We genotyped a series of 104 smokers and 117 non smokers and compared the allele frequencies between the groups. A subset (n = 87) of the smoking population also completed the Classification of Smoking by Motives questionnaire and were given scores for five criteria that drive smoking: automatic, dependence, sedative, stimulant and indulgence. Another subset (n = 52) completed the Fagerstrom Tolerance Questionnaire and were given scores for nicotine dependence. We did not find any increase in allele A1 frequency when comparing smokers to non smokers. Furthermore, neither measure of dependence was affected by possession of the A1 allele; the only difference between DRD2*A1 bearing and DRD2*A2 homozygous individuals in terms of smoking motives was found in the scores for indulgence; the former having a moderately reduced score (by 17%, p < 0.05). We conclude that, in the individuals studied, the dopamine D2 receptor TaqI locus does not affect the drive to smoke. This may be caused by the locus being unrelated to impulsive/addictive/compulsive behaviour, the polymorphism being in linkage disequilibrium with another distinct locus or, alternatively, smoking may represent a behaviour that is not directly comparable to impulsive/addictive/compulsive behaviours previously associated with the DRD2*A1 allele.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10022750     DOI: 10.1097/00008571-199804000-00005

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  11 in total

1.  Association of functional catechol O-methyl transferase (COMT) Val108Met polymorphism with smoking severity and age of smoking initiation in Chinese male smokers.

Authors:  Song Guo; Da Fang Chen; Dong Feng Zhou; Hong Qiang Sun; Gui Ying Wu; Colin N Haile; Therese A Kosten; Thomas R Kosten; Xiang Yang Zhang
Journal:  Psychopharmacology (Berl)       Date:  2007-01-06       Impact factor: 4.530

Review 2.  Association of the DRD2 gene Taq1A polymorphism and smoking behavior: a meta-analysis and new data.

Authors:  Marcus R Munafò; Nicholas J Timpson; Sean P David; Shah Ebrahim; Debbie A Lawlor
Journal:  Nicotine Tob Res       Date:  2009-01-27       Impact factor: 4.244

3.  CYP2B6 rs2279343 polymorphism is associated with smoking cessation success in bupropion therapy.

Authors:  Paulo Roberto Xavier Tomaz; Juliana Rocha Santos; Jaqueline Scholz Issa; Tânia Ogawa Abe; Patrícia Viviane Gaya; José Eduardo Krieger; Alexandre Costa Pereira; Paulo Caleb Júnior Lima Santos
Journal:  Eur J Clin Pharmacol       Date:  2015-07-08       Impact factor: 2.953

4.  Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens.

Authors:  Arthur L Brody; Mark A Mandelkern; Richard E Olmstead; David Scheibal; Emily Hahn; Sharon Shiraga; Eleanor Zamora-Paja; Judah Farahi; Sanjaya Saxena; Edythe D London; James T McCracken
Journal:  Arch Gen Psychiatry       Date:  2006-07

Review 5.  The genetics of nicotine dependence: relationship to pancreatic cancer.

Authors:  Stewart L MacLeod; Parimal Chowdhury
Journal:  World J Gastroenterol       Date:  2006-12-14       Impact factor: 5.742

6.  DAT genotype modulates brain and behavioral responses elicited by cigarette cues.

Authors:  Teresa R Franklin; Falk W Lohoff; Ze Wang; Nathan Sciortino; Derek Harper; Yin Li; Will Jens; Jeffrey Cruz; Kyle Kampman; Ron Ehrman; Wade Berrettini; John A Detre; Charles P O'Brien; Anna Rose Childress
Journal:  Neuropsychopharmacology       Date:  2008-08-13       Impact factor: 7.853

7.  Genetic analysis of polymorphisms in dopamine receptor and transporter genes for association with smoking among cancer patients.

Authors:  Marat Gordiev; Paul F Engstrom; Rustem Khasanov; Anton Moroshek; Rustem Sitdikov; Vladamir Dgavoronkov; Robert A Schnoll
Journal:  Eur Addict Res       Date:  2012-11-02       Impact factor: 3.015

Review 8.  Pharmacogenetics: a tool for identifying genetic factors in drug dependence and response to treatment.

Authors:  Margaret Mroziewicz; Rachel F Tyndale
Journal:  Addict Sci Clin Pract       Date:  2010-12

9.  Genetic variants and early cigarette smoking and nicotine dependence phenotypes in adolescents.

Authors:  Jennifer O'Loughlin; Marie-Pierre Sylvestre; Aurélie Labbe; Nancy C Low; Marie-Hélène Roy-Gagnon; Erika N Dugas; Igor Karp; James C Engert
Journal:  PLoS One       Date:  2014-12-29       Impact factor: 3.240

10.  Influences of polymorphic variants of DRD2 and SLC6A3 genes, and their combinations on smoking in Polish population.

Authors:  Alicja Sieminska; Krzysztof Buczkowski; Ewa Jassem; Marek Niedoszytko; Ewa Tkacz
Journal:  BMC Med Genet       Date:  2009-09-17       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.